Jim Broderick
Fondatore presso Palleon Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Jim Broderick
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 17 | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA.
17
| Holding Company | Miscellaneous Commercial Services | 17 |
CardioPolymers, Inc.
 CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Palleon Pharma, Inc.
 Palleon Pharma, Inc. BiotechnologyHealth Technology Palleon Pharma, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA.
2
| Subsidiary | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jim Broderick tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Chairman Director/Board Member Founder General Counsel Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| NKARTA, INC. | Biotechnology | Chief Executive Officer General Counsel Chief Administrative Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chairman | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Graduate Degree | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
TVM Capital Corp.
 TVM Capital Corp. Investment ManagersFinance TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Purdue University | College/University | Masters Business Admin Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Private Equity Investor | |
| University of Puget Sound | College/University | Undergraduate Degree Undergraduate Degree | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| OMNIAB, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Indiana University | College/University | Doctorate Degree Undergraduate Degree | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Graduate Degree Doctorate Degree | |
| IMUGENE LIMITED | Biotechnology | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor President | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Regno Unito | 2 |
| Australia | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 6 |
Posizioni
| Director/Board Member | 322 |
| Corporate Officer/Principal | 113 |
| Independent Dir/Board Member | 63 |
| Chairman | 39 |
| Undergraduate Degree | 33 |
Contatti più connessi
| Insiders | |
|---|---|
| Stephen Hoffman | 33 |
| Deepa Pakianathan | 32 |
| Jack Lasersohn | 32 |
| Jim Woody | 31 |
| Michael Wyzga | 31 |
| Olav Bergheim | 28 |
| Carolyn Bertozzi | 28 |
| Jens Eckstein | 27 |
| Terry Gould | 26 |
| Paul Hastings | 25 |
| Rajeev Dadoo | 24 |
| Denise Scots-Knight | 20 |
| Michael L. Eagle | 19 |
| William Waddill | 19 |
| Bill Burkoth | 19 |
- Borsa valori
- Insiders
- Jim Broderick
- Connessioni Società
